The surface lipids of non-tuberculous mycobacteria suppress production of phagocyte activating cytokines in human peripheral blood mononuclear cells

Microbes and Infection

Volumn 14, Issue 9, 2012, Pages 768-777

  Jönsson, Bodil ^a   Ridell, Malin ^a   Wold, Agnes E ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cytokine; Leukocytes; Lipids; Mycobacterium; Phagocytosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; MEMBRANE LIPID; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR;

ARTICLE; BACTERIAL CELL WALL; BACTERIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DOWN REGULATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM GORDONAE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS MITIS;

BLOOD; CYTOKINES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPIDS; NONTUBERCULOUS MYCOBACTERIA; PHAGOCYTES;

CORYNEBACTERINEAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM GORDONAE; NEGIBACTERIA; POSIBACTERIA; STREPTOCOCCUS MITIS;

EID: 84863084087     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.03.005     Document Type: Article

References (37)

1. Nolte N.F., Metchock B., Wallace R.J. Mycobacterium. Manual of Clinical Microbiology 1999, 399-437. ASM, Washington D.C. P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, R.H. Yolken (Eds.).
2. Flynn J.L., Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 2001, 19:93-129.
3. Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., Holland S.M., Horsburgh R., Huitt G., Iademaro M.F., Iseman M., Oliver K., Rouss S., Fordham von Reyn C., Wallace R.J., Winthorp K. An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care. Med. 2007, 175:367-416.
4. Falkinham J.O. Nontuberculous mycobacteria in the environment. Clin. Chest. Med. 2002, 23:529-551.
5. Jönsson B., Gilljam M., Lindblad A., Ridell M., Wold A.E., Welinder-Olsson C. Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. J. Clin. Microbiol. 2007, 45:1497-1504.
6. Wayne L.G., Sramek H.A. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin. Microbiol. Rev. 1992, 5:1-25.
7. Draper P. The outer parts of the mycobacterial envelope as permeability barriers. Front. Biosci. 1998, 3:D1253-D1261.
8. Brennan P.J. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2003, 83:91-97.
9. Berg S., Kaur D., Jackson M., Brennan P.J. The glycosyltransferases of Mycobacterium tuberculosis - roles in the synthesis of arabinogalactan, lipoarabinomannan, and other glycoconjugates. Glycobiology 2007, 17:35R-56R.
10. Pitarque S., Larrouy-Maumus G., Payre B., Jackson M., Puzo G., Nigou J. The immunomodulatory lipoglycans, lipoarabinomannan and lipomannan, are exposed at the mycobacterial cell surface. Tuberculosis (Edinb) 2008, 88:560-565.
11. Minnikin D.E., Minnikin S.M., Goodfellow M., Stanford J.L. The mycolic acids of Mycobacterium chelonei. J. Gen. Microbiol. 1982, 128:817-822.
12. Daffe M., Draper P. The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microb. Physiol. 1998, 39:131-203.
13. Cooper A.M., Roberts A.D., Rhoades E.R., Callahan J.E., Getzy D.M., Orme I.M. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 1995, 84:423-432.
14. Tripp C.S., Gately M.K., Hakimi J., Ling P., Unanue E.R. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J. Immunol. 1994, 152:1883-1887.
15. Langrish C.L., McKenzie B.S., Wilson N.J., de Waal Malefyt R., Kastelein R.A., Cua D.J. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 2004, 202:96-105.
16. Haque A., Easton A., Smith D., O'Garra A., Van Rooijen N., Lertmemongkolchai G., Titball R.W., Bancroft G.J. Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J. Infect. Dis. 2006, 193:370-379.
17. Hessle C.C., Andersson B., Wold A.E. Gram-positive and Gram-negative bacteria elicit different patterns of pro-inflammatory cytokines in human monocytes. Cytokine 2005, 30:311-318.
18. Casanova J.L. Mendelian susceptibility to mycobacterial infection in man. Swiss Med. Wkly. 2001, 131:445-454.
19. Cooper A.M., Solache A., Khader S.A. Interleukin-12 and tuberculosis: an old story revisited. Curr. Opin. Immunol. 2007, 19:441-447.
20. Frucht D.M., Sandberg D.I., Brown M.R., Gerstberger S.M., Holland S.M. - IL-12-Independent costimulation pathways for interferon-gamma production. Clin. Immunol. 1999, 91:234-241.
21. Lichtenauer-Kaligis E.G., de Boer T., Verreck F.A., van Voorden S., Hoeve M.A., van de Vosse E., Ersoy F., Tezcan I., van Dissel J.T., Sanal O., Ottenhoff T.H. Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency. Eur. J. Immunol. 2003, 33:59-69.
22. Miller E.A., Ernst J.D. Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed. J. Clin. Invest. 2009, 119:1079-1082.
23. Hessle C., Andersson B., Wold A.E. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect. Immun. 2000, 68:3581-3586.
24. Aloisi F., De Simone R., Columba-Cabezas S., Levi G. Opposite effects of interferon-gamma and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities. J. Neurosci. Res. 1999, 56:571-580.
25. Beamer G.L., Flaherty D.K., Assogba B.D., Stromberg P., Gonzalez-Juarrero M., de Waal Malefyt R., Vesosky B., Turner J. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J. Immunol. 2008, 181:5545-5550.
26. Hessle C.C., Andersson B., Wold A.E. Gram-negative, but not Gram-positive, bacteria elicit strong PGE2 production in human monocytes. Inflammation 2003, 27:329-332.
27. Horgen L., Barrow E.L., Barrow W.W., Rastogi N. Exposure of human peripheral blood mononuclear cells to total lipids and serovar-specific glycopeptidolipids from Mycobacterium avium serovars 4 and 8 results in inhibition of TH1-type responses. Microb. Pathog. 2000, 29:9-16.
28. Rosenkrands I., Agger E.M., Olsen A.W., Korsholm K.S., Andersen C.S., Jensen K.T., Andersen P. Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system. Infect. Immun. 2005, 73:5817-5826.
29. Goto T., Eden S., Nordenstam G., Sundh V., Svanborg-Eden C., Mattsby-Baltzer I. Endotoxin levels in sera of elderly individuals. Clin. Diagn. Lab. Immunol. 1994, 1:684-688.
30. Karlsson H., Hessle C., Rudin A. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect. Immun. 2002, 70:6688-6696.
31. Ramette A. Multivariate analyses in microbial ecology. FEMS Microbiol. Ecol. 2007, 62:142-160.
32. Barkman C., Martner A., Hessle C., Wold A.E. Soluble bacterial constituents down-regulate secretion of IL-12 in response to intact Gram-positive bacteria. Microbes Infect. 2008, 10:1484-1493.
33. Vergne I., Chua J., Singh S.B., Deretic V. Cell biology of Mycobacterium tuberculosis phagosome. Annu. Rev. Cell. Dev. Biol. 2004, 20:367-394.
34. Fieschi C., Casanova J.L. The role of interleukin-12 in human infectious diseases: only a faint signature. Eur. J. Immunol. 2003, 33:1461-1464.
35. Hessle C., Hanson L.A., Wold A.E. Interleukin-10 produced by the innate immune system masks in vitro evidence of acquired T-cell immunity to E. coli. Scand. J. Immunol. 2000, 52:13-20.
36. Silva J.S., Vespa G.N., Cardoso M.A., Aliberti J.C., Cunha F.Q. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect. Immun. 1995, 63:4862-4867.
37. Doffinger R., Altare F., Casanova J.L. Genetic heterogeneity of Mendelian susceptibility to mycobacterial infection. Microbes Infect. 2000, 2:1553-1557.